OmegaVite Science

Scientific References

• Ackman, R.G. "Safety of seal oil as a nutritional supplement. Proc. Nova Scotia Institute of Science, Vol. 41: 103-114, 1997.
• Bang, H.O., Dyerberg, J., and Hjoorne, N. The composition of food consumed by Greenland Eskimos. Acta Medica Scandinavica, Vol. 200: 69-73, 1976.
• Bonefeld-Jorgensen, E.C., Meller, S.M. and Hansen, J.C. Modulation of atherosclerosis risk factors by seal oil: a preliminary assessment. International Journal of Circumpolar Health, 60: 25-33, 2001.
• Brown, M.D., Brown, M.D., Hart, C.A., Gazi, E., Bagley, S., and Clarke, N.W. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. B.J. Cancer, Vol. 94: 842-853, 2006.
• Brox, J., Olaussen, K., Osterud, B., Elvevoll, EO., Bjornstad, E., Brattebog, G., and Iversen, H. A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects. Lipids, Vol. 36: 7-13, Jan 2001.
• Carroll, D.N., and Roth, C.T. Evidence for the cardioprotective effect of omega-3 fatty acids. The Annuals of Pharmacotherapy, Vol. 36(12): 1950-1956, 2002.
• Freeman, V.L., Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer, Vol. 101: 2744-2754, 2004.
• Gebauer, S.K., Psota, T.L., Harris, W.S., and Kris-Etherton, P.M. n-3 Fatty acid dietary recommendations and food sources to achieve essentially and cardiovascular benefits. American Journal of Clinical Nutrition, Vol. 83(6): 1526-1535, 2006.
• Holub, B.J., Docosahexaenoic Acid in Human Health. Chapter 5 in: Shahidi F and Farley, JW (eds), Omega-3 Fatty Acids Chemistry, Nutrition and Health Effects. Washington DC, American Chemical Society, 54-65, 2001.
• Horrocks, L.A. and Yeo, Y.K. Health benefits of docosahexanoic acid (DHA). Pharmacological Research, 40: 211-225, 1999.
• Jeffrey, B.G., Weisinger H.S., Neuringer, M. and Mitchell, D.C. The role of docosahexaenoic acid in retinal function. Lipids, 36(9): 859-971, 2001.
• Kanayasu-Toyoda, Morita, I., and Murota, S. Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro. Tokyo Dental and Medical University, 1996.
• Kris-Etherton, P.M., Harris, W.S., and Appel, L.J. Fish consumption, fish oil, Omega-3 fatty acids and cardiovascular disease. Circulation, Vol. 106: 2747-2757, 2002.
• Lemaitre, R.N., King, I.B., Mozaffarian, D., Kuller, L.H., Tracy, R.P., and Siscovick, D.S. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 54(4): 319-325, 1996.
• Mulvad, G. and Pedersen, HS. Orsoq Eat Meat and Blubber from Sea Mammals and avoid Cardiovascular disease. (Orsoq is the Greenlandic word for blubber) . Inuit Whaling: Inuit Circumpolar Conference, June 1992. http://www.highnorth.no/Library/Culture/or-ea-me.htm
• Murphy, M.G., Wright, V., Scott, J., Timmins, A. and Ackman, R.G. Dietary menhaden, seal, and corn oils differentially affect lipid and ex vivo eicosanoid and thiobarbituric acid-reactive substances generation in the guinea pig. Lipids, 34(2): 115-24, 1999.
• Nutrient Reference Value for Australia and New Zealand including Recommended Daily Intakes. Commonwealth Department of Health and Ageing, Australia, Ministry of Health, New Zealand, National Health and Medical Research Council. Draft: December 2004. Quoted from: Howe P.R.C., Meyer B.J., Baghurst K. Contribution of red meat to very long chain omega fatty acids (VLC omega-3) intake. Report to Meat and Livestock Australia, 2003.
• Okuyama, H., Lipid Technology Newsletter, 128-132, Dec 2000. http://www.pjbarnes.co.uk/archive/ltn2000/ltn0600.pdf
• Ren, H., Magulike, N., Ghebremeskel, K. and Crawford, M. Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 74: 157-163, 2006.
• Simon, J.A., Hodgkins, M.L., Browner, W.S., Neuhaus, J.M., Bernert, J.T. Jr, and Hulley, S.B. Serum fatty acids and the risk of coronary heart disease. American Journal of Epidemiology, Vol. 142: 469-476, 1995.
• Simopoulos, A.P.,Essential fatty acids in health and chronic disease. American Journal of Clinical Nutrition, Vol. 70(3): 560S - 569S, 1999.
• Simopolous, A.P. and Robinson, J. The Omega Plan. New York: HarperCollins, 1998.
• Terano, T., Hirai, A., Hamazaki, T., Kobayashi, S., Fujita, T., Tamura, Y. and Kumagai A. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis, 46(3): 321-31, 1983.
• Williams, C.M. and Burdge, G. Long-chain n-3 PUFA: plant v. marine sources. Proceedings of the Nutrition Society, Vol. 65: 42-50, 2006.
• Youdim, K.A., Martin, A., and Joseph, J.A. Essential fatty acids and the brain: possible health implications. International Journal of Developmental Neuroscience, Vol. 18: 383-399, 2000.